Jacobio Pharmaceuticals Group Co (HKSE:01167) 3-Year EBITDA Growth Rate : 53.80% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co 3-Year EBITDA Growth Rate?

Jacobio Pharmaceuticals Group Co's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.27.

During the past 3 years, the average EBITDA Per Share Growth Rate was 53.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jacobio Pharmaceuticals Group Co was 53.80% per year. The lowest was -29.80% per year. And the median was 4.30% per year.

Competitive Comparison of Jacobio Pharmaceuticals Group Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Jacobio Pharmaceuticals Group Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jacobio Pharmaceuticals Group Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jacobio Pharmaceuticals Group Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jacobio Pharmaceuticals Group Co's 3-Year EBITDA Growth Rate falls into.

Jacobio Pharmaceuticals Group Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Jacobio Pharmaceuticals Group Co (HKSE:01167) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Jacobio Pharmaceuticals Group Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobio Pharmaceuticals Group Co (HKSE:01167) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

JBPHF:USA

Address

No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN

Website

http://www.jacobiopharma.com

Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.

Executives

Shen Zhu	2501 Other
Treasure Partner International Limited	2501 Other
Ultimate Estate Limited	2201 Interest of corporation controlled by you
Wang Yinxiang	2501 Other
Wang Xiaojie	2307 Founder of a discretionary trust who can infl
Hu Yunyan	2501 Other
Yakovpharma Ltd	2501 Other
Willgenpharma Ltd	2501 Other
Risepharma Ltd	2101 Beneficial owner
Johwpharma Ltd	2501 Other
Hmed Ltd	2501 Other
Gloryviewpharma Ltd	2501 Other
Honourpharma Ltd	2501 Other
Blesspharma Ltd	2501 Other
Hillhouse Investment Management, Ltd.	2102 Investment manager

Jacobio Pharmaceuticals Group Co (HKSE:01167) Headlines

No Headlines